Impact of treatment with GLP-1RAs on suicide attempts in adults persons with type 2 diabetes: a retrospective comparative effectiveness study based on a global TriNetX health research database - Nassar M, Misra A, Bloomgarden Z.
OBJECTIVE: To assess the association between glucagon-like peptide-1 receptor agonists (GLP-1RA) treatment and the risk of suicide attempts in people with type 2 diabetes (T2D), with a focus on subgroups with and without a history of depression or suicide ... (Source: SafetyLit)
Source: SafetyLit - March 22, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Shark Tank ’s Mark Cuban speaks out on Ozempic, weight-loss drugs
Ozempic, the medicine known generically as semaglutide, was approved by the U.S. Food and Drug Administration (FDA) in 2017 for type 2 diabetes patients. But the drug, manufactured by Denmark-based company Novo Nordisk (NVO) , has a side effect that is changing the way many people feel about one…#fda #denmark #novonordisk #nvo #elililly #lly #mounjaro #markcuban #dallas #sharktank (Source: Reuters: Health)
Source: Reuters: Health - March 21, 2024 Category: Consumer Health News Source Type: news
Early exposure to tobacco tied to developing diabetes, study indicates
Exposure to tobacco smoke in the womb or picking up the cigarette habit in childhood or adolescence greatly increases the risk of developing type 2 diabetes in adulthood, a new study finds. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 20, 2024 Category: Consumer Health News Source Type: news
Why Your Diet Needs More Fermented Pickles
Maybe you heard somewhere that pickles are a “superfood,” and dutifully added them to your shopping list. Unfortunately, you may reach for the wrong jar, because many pickles at supermarkets aren’t especially good for you.
Scientists have made progress in separating fact from fiction when it comes to health claims about pickles: both the cucumber kind, and other types of pickled vegetables. We asked experts how to find the healthiest kinds of pickles, which benefits are backed by research, and the right amount to eat every day.
[time-brightcove not-tgx=”true”]
Pick the best pickle
Mo...
Source: TIME: Health - March 20, 2024 Category: Consumer Health News Authors: Matt Fuchs Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
Should All Diabetic Ketoacidosis Be Treated the Same? Should All Diabetic Ketoacidosis Be Treated the Same?
Using the same protocols for DKA in type 1 diabetes and DKA associated with SGLT2i use in type 2 diabetes could result in inappropriate insulin infusion dosing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Sodas, Fruit Juices Raise Boys' Odds for Type 2 Diabetes
WEDNESDAY, March 20, 2024 -- Boys who drink lots of sugary soda and fruit juice could be more likely to develop type 2 diabetes later in life, a new study has found.
Each daily 8-ounce serving of sugary drinks during a boy’s childhood is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 20, 2024 Category: General Medicine Source Type: news
Low Birth Weight Plus Overweight at Age 20 Years Linked to Increased T2D Risk
TUESDAY, March 19, 2024 -- Low birth weight combined with overweight at age 20 years is associated with an increased risk for early type 2 diabetes, according to a study published online Feb. 22 in Diabetologia. The results will also be presented at... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2024 Category: Pharmaceuticals Source Type: news
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are already extremely popular: by 2030, about 10% of the U.S. population will be on one of these drugs and the category’s sales will surpass $100 billion, according to some projections. On March 18, they got another major cultural boost from Oprah Winfrey, who shared her own experience with—and support for—these medications in an ABC special called “Shame, Blame and the Weight Loss Revolution.”
[time-brightcove not-tgx=”true”]
During the special, Winfrey talked about how using one of these weight-loss drugs (she did not say w...
Source: TIME: Health - March 19, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Congress OKs Diabetes Program Increase After Two Decades Congress OKs Diabetes Program Increase After Two Decades
The Special Diabetes program supports type 1 research and efforts to less the burden of type 2 diabetes on American Indians and Alaska Natives.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Ginger, Cinnamon, Cumin Improve Glycemic Control Ginger, Cinnamon, Cumin Improve Glycemic Control
The meta-analysis identified these spices common to the Mediterranean diet as having significant effects on glucose and insulin among subjects with type 2 diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Two companies stand at the center of the obesity drug market right now. Novo Nordisk continues to rake in money from its weight-loss drug Wegovy (and from off-label usage of its type 2 diabetes drug Ozempic.) Eli Lilly is hot on Novo Nordisk's heels with its new obesity drug Zepbound. Pfizer…#novonordisk #elililly #pfe #lilly #pf07976016 #danuglipron #pfizer #nash #vikingtherapeutics #seagen (Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news
' Making the Invisible Visible': CGMs Offer Insights for T2D'Making the Invisible Visible': CGMs Offer Insights for T2D
Results from several studies of continuous glucose monitoring for people with type 2 diabetes found improved clinical parameters even among those who don ' t use insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 14, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit?
(MedPage Today) -- Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested.
Over 6 months, adults with type 2 diabetes on subcutaneous liraglutide... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 14, 2024 Category: Cardiology Source Type: news
Disease Knowledge Limited Among Individuals With Type 2 Diabetes
WEDNESDAY, March 13, 2024 -- There is considerable room for improvement of disease knowledge among individuals with type 2 diabetes (T2D), according to a study published online March 7 in Frontiers in Public Health.Pedro L. Ferreira, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 13, 2024 Category: Pharmaceuticals Source Type: news
Amid Global GLP-1 Shortages, Doctors Prioritize Patients Amid Global GLP-1 Shortages, Doctors Prioritize Patients
Some governments are asking clinicians to reserve prescriptions for those with type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 13, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
